BioCryst Pharmaceuticals, Inc.
BCRX
$8.39
-$0.17-1.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.41% | -12.32% | -17.52% | -17.00% | -33.76% |
| Total Receivables | 32.60% | 54.15% | 38.84% | 35.06% | 19.23% |
| Inventory | 13.35% | -76.92% | -71.81% | -74.48% | -83.54% |
| Prepaid Expenses | -23.65% | -22.06% | -29.63% | -18.66% | 16.40% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1,552.48% | -83.82% | -88.36% | -48.67% | 14.04% |
| Total Current Assets | 9.63% | -8.30% | -14.92% | -14.99% | -28.88% |
|
|
|||||
| Total Current Assets | 9.63% | -8.30% | -14.92% | -14.99% | -28.88% |
| Net Property, Plant & Equipment | 0.77% | -5.49% | -5.40% | -3.67% | 29.04% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.44% | 37,807.59% | 35,330.00% | 31,636.71% | -- |
| Total Assets | -3.22% | 2.60% | -5.13% | -6.06% | -10.84% |
|
|
|||||
| Total Accounts Payable | 10.31% | -15.63% | -44.27% | 27.59% | -43.94% |
| Total Accrued Expenses | 19.55% | 16.89% | 10.12% | 34.64% | 18.99% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.15% | 29.24% | 35.23% | 1,472.66% | 1,152.21% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 37.26% | 16.62% | 6.93% | 69.20% | 38.04% |
|
|
|||||
| Total Current Liabilities | 37.26% | 16.62% | 6.93% | 69.20% | 38.04% |
| Long-Term Debt | -14.58% | -3.81% | -1.89% | -4.45% | -1.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.51% | -9.09% | -10.57% | 1.77% | 80.58% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -7.30% | -1.28% | -0.63% | 2.77% | 3.20% |
|
|
|||||
| Common Stock & APIC | 7.07% | 6.24% | 5.63% | 5.36% | 4.96% |
| Retained Earnings | -2.07% | -3.11% | -5.29% | -7.65% | -9.22% |
| Treasury Stock & Other | 195.51% | 46.82% | -31.11% | 186.63% | -19.28% |
| Total Common Equity | 11.36% | 5.09% | -4.48% | -14.01% | -22.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.36% | 5.09% | -4.48% | -14.01% | -22.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.36% | 5.09% | -4.48% | -14.01% | -22.35% |
|
|
|||||